← Browse by Condition
Medical Condition

relapsed refractory multiple myeloma rrmm

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06920251 Phase 2
Recruiting

Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy

Enrollment
40 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
View Trial →